Product Images Zilxi

This text contains information about a registered drug called "minocycline". It provides instructions and warnings for using a topical foam containing 15% of the drug. The drug is only intended for topical use and should not be used orally, ophthalmically, or intravaginally. The foam must be refrigerated until dispensed to the patient, after which it must be stored at room temperature below 25 degrees Celsius for up to 30 days. The packaging warns that the contents are flammable and under pressure, and therefore should not be punctured or exposed to heat. Dosage information can be found in the prescribing information. The text also mentions a company called "VYNE Pharmaceuticals Inc." and a location in Mohlin, Switzerland.*

This is a description of a topical foam medication called "%znx" which contains 1.5% minocycline. It is a registered trademark and should only be used for topical purposes. It is not recommended for oral, ophthalmic, or intravaginal use. The foam medication is stored at room temperature, and patients are advised to be cautious when using it due to its flammable nature. The medication comes in 15 mg of minocycline per 16 mg of minocycline to cure acne.*

Zilxi is a prescription topical foam for use on the skin and is not intended for oral, ophthalmic, or intravaginal use. It is flammable, and should not be used near fire, flames, or smoking. The medication must be stored at room temperature after dispensation to the patient, and not in the refrigerator. The usual dosage should be determined by a licensed healthcare professional according to the prescribing information. In case of suspected adverse reactions, contact VYNE Pharmaceuticals for assistance. Copyright © 2020, VYNE Therapeutics. All rights reserved. Not available.*

O zilxi is a topical foam, 1.5% (minocycline) used for topical purposes only. It should not be consumed orally, ophthalmically or vaginally. The package has instructions on how to apply, store, and discard the product. It contains warnings about avoiding exposure to heat, flames, and smoking while using the product. One container of the product contains 15g of minocycline equivalent to 16mg.*

This text appears to be a label for the medication XVYNE, a topical foam made by VYNE Therapeutics. It contains warnings and instructions for storing and using the foam, as well as a phone number for reporting adverse reactions. The dosage information is not provided in this text.*

The text contains information about a pharmaceutical product named "minocycline". It is a topical foam with a concentration of 1.5%. The product is not meant for oral, ophthalmic, or intravaginal use. The user should store it at room temperature and avoid exposing it to fire or smoke. The dosage instructions recommend using a small amount of foam on the affected area. The product is available only with a prescription.*

This text is a disclaimer/notification for a trademark registration and some cautionary notes for storing and using a product called "Minocycling" produced by VYNE Therapeutics Inc. The text includes a warning about the flammability of the product and advises against smoking during or immediately after applying the product. The text also provides contact information for reporting suspected adverse reactions and instructions for storing the product at room temperature. The text mentions that the usual dosage should be referred to as per the prescribing information and the product is suitable for topical use only.*